SEC Form 5 · accession 0001209191-18-010225
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corp /ny Greenbelt
Other
Period of report
Dec 31, 2017
Accepted (ET)
Feb 14, 2018 · 9:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par valueF1 | Dec 1, 2017 | G | 100,000 | — | D | 1,043,346 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations.
Remarks
Greenbelt Corp. is an affiliate of Alfred D. Kingsley, a director of BioTime, Inc.